Jacques PFISTER
MBA
-
Previously President of "CCI Marseille Provence"
CCI Marseille Provence
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
Marseille Immunopole is one spearheads of the Aix-Marseille-Provence Metropolis excellence, in research as in the economy field.
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
CCI Marseille Provence, already at the initiative of the Eurobiomed cluster, accompanies this ambitious metropolitan project in its entrepreneurial and international dimensions. Alongside with its institutional partners, it facilitates the development of companies and contributes to the development of this project.
Health is a major economical sector of Aix-Marseille-Provence Metropolis. Combining a high-level public and private healthcare offer with high research potential, it constitutes an expanding strategic sector for CCI Marseille Provence, which gave rise to numerous ambitious and innovative entrepreneurial initiatives.
Combined successes of Éric Vivier, a world-renowned researcher, Hervé Brailly and Vincent Fert, entrepreneurs who have both developed their companies in a remarkable way, illustrate perfectly the dynamism and the innovative capacity of our territory in this essential area.
Have a look on our testimonies
The Pioneer Project is unique as a strong public/private partnership between academia, a medical cancer center, 3 biotechs and a major pharma
Bernard A. FOX
Providence Cancer Institute, Portland, Oregon | UbiVac
Our study models help to identify new potential therapeutic targets in preclinical models of personalized medicine.
Michel AURRAND-LIONS
AMU, IPC, CRCM
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.
Fabrice BARLESI
AMU, Gustave Roussy, The Pioneer Project
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA
your commitment to MI